Making Science Investable
From Molecule to Market.
From Molecule to Market.
Senz Life Sciences
Senior-level advisory for biotech, pharma and consumer health preparing for investment or M&A.
Former pharma leaders with over 50 years of combined experience guiding innovation to market.
Selective engagements. Confidential.
Strong Science Is Not Enough.
Many founders believe:
“If the data is good, investors will see it.”
But capital does not follow science alone.
It follows:
Clear positioning
Market logic
Commercial credibility
Realistic value creation
Strategic alignment
Without that translation, even strong innovation struggles to secure the right investment or partnership.
At Senz Life Sciences, we close that gap.
What We Do
We help companies prepare for serious investment or M&A discussions.
Before negotiation begins.
Before valuation is fixed.
Before strategic mistakes become expensive.
We work with you to:
Define the true value of your innovation
Position your asset in a compelling market context
Clarify growth and exit scenarios
Develop professional investment materials
Identify and approach the right strategic candidates
We prepare the ground for strong deals.
What We Do
We help companies prepare for serious investment or M&A discussions.
Before negotiation begins.
Before valuation is fixed.
Before strategic mistakes become expensive.
We work with you to:
Define the true value of your innovation
Position your asset in a compelling market context
Clarify growth and exit scenarios
Develop professional investment materials
Identify and approach the right strategic candidates
We prepare the ground for strong deals.
Our 3P Pathway
Position
Define the commercial potential of your innovation.
Clarify market opportunity, differentiation, risks, and value logic.
Package
Develop clear materials that support investment or M&A discussions.
Teasers, presentations, structured information documents.
Partner
Identify and approach the right strategic or industry partners.
Guide discussions toward alignment and opportunity.
When needed, we collaborate with trusted transaction and legal specialists to support formal deal execution.
Explore Fit with a Strategic Review Session
Who We Work With
We partner with biotech, pharma, and consumer health companies that:
Have validated science or a strong innovation
Are preparing for investment, strategic partnership, or M&A
Need senior commercial expertise and access to a broad industry network
Value structured, high-level advisory
We are based in Europe and South-East Asia. Active globally.
Why Senz Life Sciences
Clinical & Commercial Depth
We combine medical, marketing, and general management experience from global pharma and consumer health.
Senior Only Engagement
Every project is led personally by Coert Huijbregsen, MD, MBA and Drs. Karin van Zuilen, pharmacist. No junior teams. No handoffs.
Industry
Network
Deep, long-term relationships across pharma and consumer health globally.
Access to senior decision-makers involved in investment and partnership discussions.
Structured
Thinking
Clear analysis. Clear positioning. Clear communication.
Investors and strategic partners respond to clarity.
What Clients Say
“They combine medical depth with strong strategic and financial insight.”
Senz combines strategic insight, financial expertise, and strong presentation skills. Their support is ideal for organizations focused on bringing innovation to life.
Prof. Dr. Hans U. Baer
Founder Baermed / University of Bern Switzerland
“They helped us shape a compelling story that honored the science.”
We had groundbreaking science, but the message was not landing with investors. Senz structured our materials, supported outreach, and helped open the right doors.
Sara Isbell
CEO, Enabled Therapeutics
USA
Request a Confidential Strategic Review Session
Selected Transaction Experience
Over the course of our careers, we have supported:
Licensing agreements exceeding €10 million
Cross-border product acquisitions and divestments
Sale of branded pharmaceutical portfolios
Company sales in Switzerland and Germany
Production and distribution agreements across Europe
Transaction sizes ranging from multi-million euro licensing deals to full company exits.
We also bring deep experience from leadership roles within international pharma organizations.
Over the course of our careers, we have supported:
Licensing agreements exceeding €10 million
Cross-border product acquisitions and divestments
Sale of branded pharmaceutical portfolios
Company sales in Switzerland and Germany
Production and distribution agreements across Europe
Transaction sizes ranging from multi-million euro licensing deals to full company exits.
We also bring deep experience from leadership roles within international pharma organizations.
Lead by Former Pharma Executives
Lead by Former Pharma Executives
Coert Huijbregsen, MD, MBA
Former General Manager and Marketing Director within international pharma organizations.
Extensive experience in financial modeling, business planning, and commercial strategy for growth and transactions.
Coert Huijbregsen, MD, MBA
Former General Manager and Marketing Director within international pharma organizations.
Extensive experience in financial modeling, business planning, and commercial strategy for growth and transactions.
Drs. Karin van Zuilen, Pharmacist
Former Global Marketing Director with over 30 years of leadership in pharma and consumer health.
Specialist in portfolio strategy, global brand positioning, and commercialization of complex innovations.
Combined experience spanning:
Rx | OTC | Hospital | Consumer health | International markets
The Real Risk Is Not the Science
The real risk is:
A failed fundraising round
An undervalued exit
A poorly structured licensing deal
Years of delay
Strategic misalignment
A weak preparation phase can reduce valuation significantly.
We exist to prevent that.
Frequently Asked Questions
Question 1: Do you work with companies already in fundraising discussions?
Yes. We often step in to strengthen positioning before or during investor conversations.
Question 2: Do you participate in negotiations?
We focus on preparation, strategic positioning and outreach. When needed, we collaborate with trusted transaction and legal specialists.
Question 3: Do you work with competitors in the same therapeutic area?
We are highly selective and manage conflicts carefully. Confidentiality is fundamental.
Question 4: What stage should a company be in?
Typically clinical-stage biotech or companies with validated innovation preparing for investment or strategic options
Selective Engagement
We work with a limited number of companies each year.
If we engage, we commit fully.
Our role is not to produce slides.
It is to ensure you approach investors or strategic buyers with a clear, defensible value story.
Ready to Explore Fit?
If you are preparing for investment or evaluating strategic options, you may request a confidential Strategic Review Session.
Ready to Explore Fit?
If you are preparing for investment or evaluating strategic options, you may request a confidential Strategic Review Session.
To ensure alignment, we ask you to complete a short qualification form.
If there is a strong fit, we will schedule a private discussion.